| Popis: |
PURPOSE: De novo mutations (DNMs) are a well-recognized cause of genetic disorders. The contribution of DNMs to hearing loss (HL) is poorly characterized. We aimed to evaluate the rate of DNMs in HL-associated genes and assess their contribution to HL. METHODS: Targeted genomic enrichment and massively parallel sequencing were used for molecular testing of all exons and flanking intronic sequences of known HL-associated genes, with no exclusions on the basis of type of HL or clinical features. Segregation analysis was performed and previous reports of DNMs in PubMed and ClinVar were reviewed to characterize the rate, distribution, and spectrum of DNM in HL. RESULTS: DNMs were detected in 10% (24/238) of trios for whom segregation analysis was performed. Overall, DNMs were causative in at least ~1% of probands for which a genetic diagnosis was resolved, with marked variability based on inheritance mode and phenotype. DNMs of MITF were most common (21% of DNMs), followed by GATA3 (13%), STRC (13%), and ACTG1 (8%). Review of reported DNMs revealed gene-specific variability in contribution of DNM to the mutational spectrum of HL-associated genes. CONCLUSION: DNMs are a relatively common cause of genetic HL, and must be considered in all cases of sporadic HL. |
